Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 135.15M P/E - EPS this Y 1.80% Ern Qtrly Grth -
Income -76.95M Forward P/E -2.29 EPS next Y - 50D Avg Chg -29.00%
Sales 673k PEG - EPS past 5Y - 200D Avg Chg -19.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -65.00%
Recommedations 2.20 Quick Ratio 2.96 Shares Outstanding 132.64M 52W Low Chg 129.00%
Insider Own 11.58% ROA -41.47% Shares Float 120.38M Beta 1.03
Inst Own 26.49% ROE -1,103.79% Shares Shorted/Prior 9.98M/8.86M Price 1.28
Gross Margin 6.98% Profit Margin - Avg. Volume 2,351,438 Target Price 4.33
Oper. Margin -2,680.24% Earnings Date Mar 27 Volume 1,882,621 Change -8.57%
About Gamida Cell Ltd.

Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with hematologic malignancies, as well as in Phase II clinical trials in patients with severe aplastic anemia. It is also developing GDA-201, an investigational NK cell-based cancer immunotherapy, which is in Phase I/II studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. The company was incorporated in 1998 and is headquartered in Jerusalem, Israel.

Gamida Cell Ltd. News
03/27/24 Q4 2023 Gamida Cell Ltd Earnings Call
03/27/24 Gamida Cell Announces Commencement of Restructuring Process Supported by Highbridge Capital Management
03/27/24 Gamida Cell Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Company Update
03/22/24 Gamida Cell to Report Fourth Quarter and Full-Year 2023 Financial Results
02/23/24 Gamida Cell Data Presented at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
06:00 AM Gamida Cell Actively Pursuing Strategic Alternatives
01/17/24 Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®
11/27/23 Gamida Cell to Host Virtual Thought Leader Fireside Chat on December 4, 2023
11/20/23 Gamida Cell to Present Corporate Highlights at the Piper Sandler 35th Annual Healthcare Conference
11/15/23 Gamida Cell Ltd. (NASDAQ:GMDA) Q3 2023 Earnings Call Transcript
11/15/23 Q3 2023 Gamida Cell Ltd Earnings Call
11/14/23 Gamida Cell Reports Third Quarter 2023 Financial Results and Provides Company Update
11/04/23 Gamida Cell Presents New Data on Allogeneic Stem Cell Therapy Omidubicel and Natural Killer (NK) Cell Therapy Candidate GDA-201 at Society for Immunotherapy of Cancer (SITC) Annual Meeting
11/01/23 Gamida Cell to Report Third Quarter 2023 Financial Results
10/16/23 Gamida Cell Reports Preliminary Data from Phase 1 Study of Natural Killer (NK) Cell Therapy Candidate GDA-201
10/09/23 Gamida Cell Issues Update on Israel Operations
10/02/23 Gamida Cell to Present Corporate Highlights at 2023 Cell & Gene Meeting on the Mesa
05:10 AM Pleasing Signs As A Number Of Insiders Buy Gamida Cell Stock
09/28/23 Gamida Cell to Present at Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting
09/27/23 First Patient Receives Gamida Cell's Omisirge™ (omidubicel-onlv)
GMDA Chatroom

User Image INTL Posted - 10 minutes ago

$GMDA April 4th meeting will flip this from a performance based payout to asset/ip payout. Best cased scenario for shareholders. Should pay much higher.

User Image Francois0515 Posted - 17 minutes ago

$GMDA An urgent hearing is hereby scheduled for next Thursday, April 4, 2024 at 11:00 a.m. The motion is exceptional compared to similar motions or, more precisely, it is very unique. On the face of it, if the motion and this decision are served on the relevant parties that are likely to be harmed, and if these parties are given the opportunity to address the motion, the chances of receiving the main remedies are higher. For example, the request to order a mechanism for approving the arrangement even without convening a creditors’ meeting and without an arrangement administrator. It is clarified that these matters will be considered at the specially scheduled hearing after receiving the position of the Commissioner.

User Image jim3100 Posted - 36 minutes ago

$GMDA Reading through the 8k, so company states that there were offers that somehow were not actionable. Put the date for offers up to feb 9. way to late to actually do a r/s. and sell the shares. This was intentional, zero doubt on that. Made zero effort to actually raise money for last 6 months. All other creditors are paid so they can continue to do business. Just highbridge owed. there is a deal brewing, just after they jetisson shareholders and go bk to make it all legal. 30 mil wont make it long for them, hence why the contract extensions till september.

User Image topochico78 Posted - 1 hour ago

$GMDA We need to make life very difficult for Cooley LLP also

User Image topochico78 Posted - 1 hour ago

$GMDA someone on this board many weeks ago posted an article about an employee at Cooley LLP. I’d like to find that post again.

User Image Matrixtrade Posted - 1 hour ago

$GMDA the latest filing looks like it's back firing on them. Their scheme and fraud.

User Image gris803 Posted - 1 hour ago

$GMDA do you know the craziest part about all this is that management and the boards RSU vest upon change of control.

User Image cantreadachart Posted - 1 hour ago

$GMDA I would say their new filing is a result of lawyers asking for answers. I’m no lawyer but according to google if they are going to cancel shares and they are not going bankrupt then shares must be bought back.

User Image therightpicks Posted - 1 hour ago

$GMDA I have a question. What happens if the Israeli court rejects them from going private? Will they then go bankcrupt? Or will they try a reverse split? Or sell the company outright? Will those that are still holding shares fare any better?

User Image jsm0901 Posted - 1 hour ago

$GMDA if I ever meet some of the inhuman disgusting thieves who have stolen my entire 10 year savings, I can say with 100% certainty that they will pay for it, one way or another.

User Image Magnificient Posted - 2 hours ago

$GMDA OMG what happened here.

User Image Michaelkhouri88 Posted - 2 hours ago

$GMDA 'The CVR rights will be designed in the most effective way from the taxation perspective, and in such manner that they will not be deemed to be a security that requires registration under the securities laws of the United States (U.S. Securities Act of 1933 and the U.S. Securities Exchange Act of 1934) and, in any event, as will be agreed between the Company and the Lender.'

User Image Michaelkhouri88 Posted - 2 hours ago

$GMDA in the March 29th Sec filing The economic expert opinion attached as Appendix A to this Arrangement (the “Economic Expert Opinion”) has been submitted to the board of directors of the Company, and, according to the Economic Expert Opinion, the value of the assets of the Company is lower than the value of its liabilities, and the conditions prescribed under the Bankruptcy Law (as defined below) for submitting the Arrangement for the approval of the shareholders of the Company are not satisfied;

User Image Michaelkhouri88 Posted - 2 hours ago

$GMDA they just filed another SEC filing. https://stocktwits.com/symbol/GMDA The Staff further notified the Company that trading of the Ordinary Shares will be suspended at the opening of business on April 8, 2024, and a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Ordinary Shares from listing on Nasdaq. The Company cautions that trading in the Ordinary Shares during the pendency of the restructuring proceeding is highly speculative and poses substantial risks. Trading prices for the Ordinary Shares may bear little or no relationship to the actual recovery, if any, by holders of the Ordinary Shares in the Restructuring Proceeding. The Company expects that holders of the Ordinary Shares could experience a significant or complete loss on their investment, depending on the outcome of the restructuring proceeding.

User Image gris803 Posted - 2 hours ago

$GMDA I’m hopeful we hear the news that Terry, Julian, Abby and highbridge staff were in F*tal car acc*dents over this holiday weekend. They deserve it!🤷🏻‍♂️🤷🏼‍♂️

User Image shayBla Posted - 4 hours ago

$GMDA There is an opportunity here. The company has one approved product, a product line under development and innovative means of production. Decades of knowledge and research. The takeover proposal they presented is done at a minimal cost and while erasing any value for the shareholders, the future compensation path they presented is also vague and non-transparent. A pharmaceutical company with an interest in the products and the manufacturing facility that submits a purchase offer for unsold shares will gain control of all of them and overcome the delisting offer for just over $100 million. The outline they presented requires the approval of a judge and the approval of the SEC, and these will not be accepted if there is a proposal that does not delete the shareholders. I hope there is a company interested, if so they should first collect shares on the free market at a cost of cents and then submit an offer. I call on those who can present the case to interested parties

User Image Harold_the_Hedge Posted - 5 hours ago

$GMDA for me it is pretty obvious they wanted retail to be wiped out. I have seen companies make stock offerings at 0.02 cents, or 0.10 cents. We all voted for 200M more shares to be printed. They did not use one single new printed share, even though they were in dire need of money. Ceo has been screaming significant interest from multiple partners!! It just doens't add up at all with their hideous play. Fucking scam!!

User Image petoss Posted - 6 hours ago

$GMDA this will be soon on court, for fraud .. CEO jail time

User Image JBG99 Posted - 6 hours ago

$GMDA After some time to process the ongoing shenanigans here with the Gamida Cell management team, Highbridge et all. I will also file SEC report and review my legal options. Even if I get nothing from this, making life more difficult for them and ensuring it does not happen again is a top priority for me. Again, this is a learning experience for me and many others, but we do need to fight back as much as we can. I do believe Abbi has made an extremely terrible mistake as CEO, and she and her team should suffer consequences. On a side note, if anyone needs to let off some steam, feel free to message me. Also, If there is a class action lawsuit, please DM me. Best of luck and I wish you all a happy Good Friday and Easter Sunday . Even though we've sustained great losses, please try and find time to be thankful for the many blessings you may have in your life, such as family and friends.

User Image nasdaqgogo Posted - 9 hours ago

$GMDA cathie wood loosing money too?

User Image IgniteTheYes Posted - 9 hours ago

$GMDA received same response yesterday. Has anyone heard from the SEC aside from the generic response? I really hope we garner enough complaints to catch their attention

User Image sean1122 Posted - 10 hours ago

$GMDA It would be great to see a response on this situation from Danny Dealz as he seems to have a large following...anybody contact him, well then you should!

User Image sean1122 Posted - 10 hours ago

$GMDA Institutional investors would have lost also, its important to check any holder that may have sold all their shares in the last week to See if Abbey and Gamida tipped off their friends....I am messaging them on linkedin and it doesnt hurt to message everyone that was party to this...Abbey, Michele, Terry, Ronit, Chairwoman Shaun, Julian Adams AND Highbridge, they all need to be sent correspondence that they all are responsible for stealing peoples lives and livelihoods....

User Image roseylv Posted - 10 hours ago

$GMDA what’s about the institutional investors? They all had quite a bit at stake. Are we to believe they all lost everything like us?

User Image nik4 Posted - 10 hours ago

$GMDA SEC Response - File HO::~01381262~::HO Inbox [email protected] 5:31 PM (5 hours ago) to me Dear Nik: Thank you for contacting the U.S. Securities and Exchange Commission (SEC). We appreciate the opportunity to review your concerns. The SEC’s Office of Investor Education and Advocacy processes many comments from individual investors and others. We keep records of the correspondence we receive in a searchable database that SEC staff may make use of in inspections, examinations, and investigations. In addition, some of the correspondence we receive is referred to other SEC offices and divisions for their review. If they have any questions or wish to respond directly to your comments, they will contact you. Sincerely, Office of Investor Education and Advocacy U.S. Securities and Exchange Commission (800) 732-0330 www.sec.gov www.Investor.gov www.twitter.com/SEC_Investor_Ed please keep writing

User Image Stockholm111 Posted - 10 hours ago

$GMDA We need to publicly shame these criminals. Any thoughts ?

User Image Analyst_X Posted - 10 hours ago

$GMDA Management is no doubt in the wrong here. I don't care what reasoning they have, forward looking statements or not, you just don't announce multiple deal proposals oral and written only to allow the lender to take over the company. This is obviously orchestrated theft and I am compelled to find a way to screw these people over one day if I ever get the opportunity as I work in the industry. I have a hard time believing anyone would pass up this company on doing some deal that is better than CVRs with insane targets. Any other company with a sales team in these transplant center accounts should have done a deal with them to add Omisirge to their bag. Don't ever forget their names, including Highbridge Capital.

User Image topochico78 Posted - 10 hours ago

$GMDA so if you own cvr in the new private company, are you entitled to their quarterly financial statements? Would love to have share just so I can monitor progress.

User Image catherinejames Posted - 11 hours ago

$GMDA Analyst price target for next week.. ✅ https://join-stock-trading-group.marketwatcher.xyz

User Image topochico78 Posted - 11 hours ago

$GMDA Gamida Facebook page open for comments. Let’s have them shut those down also

Analyst Ratings
JMP Securities Market Perform Jan 29, 24
Needham Buy Dec 5, 23
Piper Sandler Overweight Nov 15, 23
HC Wainwright & Co. Buy Nov 15, 23
JMP Securities Market Outperform Sep 28, 23
HC Wainwright & Co. Buy Aug 16, 23
Needham Buy Aug 15, 23
Needham Buy Jun 30, 23
HC Wainwright & Co. Buy May 22, 23